These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
207 related articles for article (PubMed ID: 14606105)
1. Role of VEGF and CD44v6 in differentiating benign from malignant ascites. Dong WG; Sun XM; Yu BP; Luo HS; Yu JP World J Gastroenterol; 2003 Nov; 9(11):2596-600. PubMed ID: 14606105 [TBL] [Abstract][Full Text] [Related]
2. Detection of type IV collagenase activity in malignant ascites. Sun XM; Dong WG; Yu BP; Luo HS; Yu JP World J Gastroenterol; 2003 Nov; 9(11):2592-5. PubMed ID: 14606104 [TBL] [Abstract][Full Text] [Related]
3. Correlation of cytologic examination with ELISA assays for hyaluronan and soluble CD44v6 levels in evaluation of effusions. Afify A; Lynne LC; Howell L Diagn Cytopathol; 2007 Feb; 35(2):105-10. PubMed ID: 17230576 [TBL] [Abstract][Full Text] [Related]
4. The clinical significance of vascular endothelial growth factor in malignant ascites. Zhan N; Dong WG; Wang J Tumour Biol; 2016 Mar; 37(3):3719-25. PubMed ID: 26462841 [TBL] [Abstract][Full Text] [Related]
5. [Clinical significance of detecting VEGF, CD44v6, MMP-2, and MMP-9 in malignant ascites]. Sun XM; Dong WG; Yu BP; Luo HS; Yu JP Ai Zheng; 2004 Jan; 23(1):85-9. PubMed ID: 14720382 [TBL] [Abstract][Full Text] [Related]
6. Markedly elevated levels of vascular endothelial growth factor in malignant ascites. Zebrowski BK; Liu W; Ramirez K; Akagi Y; Mills GB; Ellis LM Ann Surg Oncol; 1999 Jun; 6(4):373-8. PubMed ID: 10379858 [TBL] [Abstract][Full Text] [Related]
8. Clinical significance of vascular endothelial growth factor and endostatin levels in the differential diagnosis of malignant and benign ascites. Cheng D; Liang B; Kong H Med Oncol; 2012 Jun; 29(2):1397-402. PubMed ID: 21556933 [TBL] [Abstract][Full Text] [Related]
9. Serum concentration of CD44 variant 6 and its relation to prognosis in patients with gastric carcinoma. Saito H; Tsujitani S; Katano K; Ikeguchi M; Maeta M; Kaibara N Cancer; 1998 Sep; 83(6):1094-101. PubMed ID: 9740073 [TBL] [Abstract][Full Text] [Related]
10. Prognostic significance of vascular endothelial growth factor expression in ovarian cancer patients: a long-term follow-up. Rudlowski C; Pickart AK; Fuhljahn C; Friepoertner T; Schlehe B; Biesterfeld S; Schroeder W Int J Gynecol Cancer; 2006; 16 Suppl 1():183-9. PubMed ID: 16515588 [TBL] [Abstract][Full Text] [Related]
11. The vascular endothelial growth factor receptor KDR/Flk-1 is a major regulator of malignant ascites formation in the mouse hepatocellular carcinoma model. Yoshiji H; Kuriyama S; Hicklin DJ; Huber J; Yoshii J; Ikenaka Y; Noguchi R; Nakatani T; Tsujinoue H; Fukui H Hepatology; 2001 Apr; 33(4):841-7. PubMed ID: 11283848 [TBL] [Abstract][Full Text] [Related]
12. Expression and correlation of CD44v6, vascular endothelial growth factor, matrix metalloproteinase-2, and matrix metalloproteinase-9 in Krukenberg tumor. Lou G; Gao Y; Ning XM; Zhang QF World J Gastroenterol; 2005 Aug; 11(32):5032-6. PubMed ID: 16124061 [TBL] [Abstract][Full Text] [Related]
13. A Novel Combination of C-Reactive Protein and Vascular Endothelial Growth Factor in Differential Diagnosis of Ascites. Abdel-Razik A; Mousa N; Elalfy H; Sheta TF; Awad M; Abdelsalam M; Elhelaly R; Elzehery R; Gouda NS; Eldars W J Gastrointest Cancer; 2017 Mar; 48(1):50-57. PubMed ID: 27614744 [TBL] [Abstract][Full Text] [Related]
14. [Expression and clinical significance of CD44v6 and sCD44v6 in gastric carcinoma]. Zhou DH; Ma ZM; Chen Y Zhonghua Zhong Liu Za Zhi; 2007 Nov; 29(11):833-7. PubMed ID: 18396641 [TBL] [Abstract][Full Text] [Related]
16. The use of pleural fluid sCD44v6/std ratio for distinguishing mesothelioma from other pleural malignancies. Porcel JM; Esquerda A; Rodriguez-Panadero F; MartÃnez-Iribarren A; Bielsa S J Thorac Oncol; 2011 Jan; 6(1):190-4. PubMed ID: 21079519 [TBL] [Abstract][Full Text] [Related]
17. C-reactive protein and insulin-like growth factor-1 in differential diagnosis of ascites. Abdel-Razik A; Eldars W; Elhelaly R; Elzehery R J Gastroenterol Hepatol; 2016 Nov; 31(11):1868-1873. PubMed ID: 27010362 [TBL] [Abstract][Full Text] [Related]
18. Clinical value of tumour markers and serum-ascites albumin gradient in the diagnosis of malignancy-related ascites. Chen SJ; Wang SS; Lu CW; Chao Y; Lee FY; Lee SD; Wu SL; Cherng KL; Lo KJ J Gastroenterol Hepatol; 1994; 9(4):396-400. PubMed ID: 7948823 [TBL] [Abstract][Full Text] [Related]
19. Vascular endothelial growth factor (VEGF) levels as a tool to discriminate between malignant and nonmalignant ascites. Nascimento I; Schaer R; Lemaire D; Freire S; Paule B; Carvalho S; Meyer R; Schaer-Barbosa H APMIS; 2004 Sep; 112(9):585-7. PubMed ID: 15601306 [TBL] [Abstract][Full Text] [Related]
20. Vascular endothelial growth factor levels in ascites between chemonaive and chemotreated patients. Lee HK; Chae HS; Kim JS; Kim HK; Cho YS; Rho SY; Kang JH; Cho SG; Jang HS; Han K Yonsei Med J; 2008 Jun; 49(3):429-35. PubMed ID: 18581593 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]